4 Healthcare Stock Stories for Tuesday Wellness

| + More Articles
  • Like on Facebook
  • Share on Google+
  • Share on LinkedIn

Oncolytics Biotech (NASDAQ:ONCY): Closing price $3.55

On Monday, the company announced a poster presentation that covers positive preliminary results from a Phase I evaluation examining the intravenous administration of Reolysin in combination with Folfiri in patients suffering from metastatic colorectal cancer (REO 022). The results were presented at the ASCO Gastrointestinal Cancers Symposium in San Francisco, which took place from January 24th through the 26th.

onc

Markets are at 5-year highs! Discover the best stocks to own. Click here for our fresh Feature Stock Pick now!

More Articles About:

To contact the reporter on this story: staff.writers@wallstcheatsheet.com To contact the editor responsible for this story: editors@wallstcheatsheet.com

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business